Manulife (Manufacturers Life Insurance)’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,673
Closed -$513K 3102
2024
Q1
$513K Buy
14,673
+1,286
+10% +$46.9K ﹤0.01% 2202
2023
Q4
$509K Sell
13,387
-281
-2% -$6.02K ﹤0.01% 2162
2023
Q3
$251K Buy
13,668
+15
+0.1% +$314 ﹤0.01% 2459
2023
Q2
$354K Buy
13,653
+1,036
+8% +$24.2K ﹤0.01% 2254
2023
Q1
$238K Hold
12,617
﹤0.01% 2440
2022
Q4
$311K Buy
12,617
+406
+3% +$11.9K ﹤0.01% 2283
2022
Q3
$219K Sell
12,211
-459
-4% -$8.27K ﹤0.01% 2528
2022
Q2
$144K Buy
12,670
+934
+8% +$13.7K ﹤0.01% 2807
2022
Q1
$261K Sell
11,736
-2,841
-19% -$72.5K ﹤0.01% 2598
2021
Q4
$637 Sell
14,577
-598
-4% -$23.9K ﹤0.01% 2107
2021
Q3
$505K Sell
15,175
-1,399
-8% -$42.6K ﹤0.01% 2278
2021
Q2
$456K Buy
+16,574
New +$345K ﹤0.01% 2503

Other funds holding INBX

Manulife (Manufacturers Life Insurance)'s INBX Position: Q2 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 14,673 shares — an estimated $513K sold.

Manulife (Manufacturers Life Insurance) first reported a position in INBX in Q2 2021 and held it in 12 quarters. The position peaked at $513K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,673 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $513K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Inhibrx, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Manulife (Manufacturers Life Insurance)'s Inhibrx, Inc. Common Stock position peaked at $513K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2024, filed 14 Aug 2024.